Bone marrow micrometastases in breast cancer patients

Breast Cancer Research and Treatment

Volumn 58, Issue 2, 1999, Pages 123-130

  Molino, Annamaria ^a,e   Pelosi, Giuseppe ^b   Micciolo, Rocco ^c   Turazza, Monica ^d   Nortilli, Rolando ^a   Pavanel, Flavia ^a   Cetto, Gian Luigi ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF TRENTO   (Italy)

^d Ospedale S Cuore   (Italy)

^e Div Clinicizzata di Oncol Med   (Italy)

Author keywords

Bone marrow; Breast cancer; Micrometastases

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; COVARIANCE; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; LEUKOCYTE; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE;

ANTIBODIES, MONOCLONAL; BIOPSY, NEEDLE; BONE MARROW; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0033403238     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006336100142     Document Type: Article

References (34)

1. 1. Harris JR, Morrow M, Bonadonna G: Cancer of the breast. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology, 4th edition. Lippincott, Philadelphia, PA, 1993, pp 1264-1332
2. 2. Coombes RC: The staging of human breast cancer: Physical staging technique. In: Coombes RC, Powles YJ, Ford HT, Gazet JC (eds), Breast Cancer Management: The Experience of the Combined Breast Clinic, St. George's Hospital and the Royal Marsden Hospital. Academic Press, London, 1981, pp 77-95
3. 3. Coombes RC, Dearnaley DP, Buckman R: Detection of bone metastases in patients with breast cancer. Invasion Metastasis 2: 177-184, 1982
4. 4. McNeil BJ, Pace PD, Gray EB, Adelstein SJ, Wilson RE: Pre-operative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147: 745-748, 1978
5. 5. Salvadori B, Squicciarini P, Rovini D, Orefice S, Andreola S, Rilke F, Barletta L, Ménard S, Colnaghi ML: Use of monoclonal antibody MBrl to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer 26 (8): 865-867, 1990
6. 6. Kirk SJ, Cooper GG, Hoper M, Watt PCH, Roy AD, Odling-Smee W: The prognostic significance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 16: 481-485, 1990
7. 7. Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer: Long-term follow-up of the first patient cohort. Eur J Cancer 27(3): 236-239, 1991
8. 8. Mansi JL, Easton D, Berger U, Gazet JC, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur J Cancer 27(12): 1552-1555, 1991
9. 9. Cote RJ, Rosen PP, Old LJ, Osborne MP: Detection of bone marrow micrometastases in patients with early-stage breast cancer. Diagn Oncol 1: 37-42, 1991
10. 10. Osborne MP: Breast cancer micrometastases in bone marrow detected by fluorescein-labelled monoclonal antibodies: Predictor of early relapse. Conference on cancer micrometastasis: biology, methodology, and clinical significance. Bethesda, USA, June 25, 1992 (abstr)
11. 11. Cote RJ: Detection and prognostic significance of occult bone marrow micrometastases in patients with early stage breast carcinoma. Conference on cancer micrometastasis: biology, methodology, and clinical significance. Bethesda, USA, June 25, 1992 (abstr)
12. 12. Schlimok F, Lindemann F, Holzmann K, Witte J, Renner D, Riethmuller G: Prognostic significance of disseminated tumor cells detected in bone marrow of patients with breast and colorectal cancer: A multivariate analysis. Conference on cancer micrometastasis: biology, methodology, and clinical significance. Bethesda, USA, June 25, 1992 (abstr)
13. 13. Diel IJ, Kaufmann M, Goemer R, Costa SD, Kaul S, Bastert G: Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol 10(10): 1534-1539, 1992
14. 14. Merkle E, Henke A, Bahr I, Buhner M, Lang N: Tumor cell detection in bone marrow of primary breast cancer patients. 18th International Congress of Chemotherapy. Stockholm, Sweden, June 27-July 2, 1993 (abstr)
15. 15. Harbeck N, Untch M, Pache L, Eiermann W: Tumor cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up. Br J Cancer 69: 566-571,1994
16. 16. Ménard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi P, Salvadori B, Veronesi U, Colnaghi MI: Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumor prognostic features. Br J Cancer 69: 1126-1129, 1994
17. 17. Molino A, Pelosi G, Turazza MI, Sperotto L, Bonetti A, Nortilli R, Fattovich G, Alaimo C, Piubello Q, Pavanel F, Micciolo R, Cetto GL: Bone marrow micrometastases in 109 breast cancer patients: Correlation with clinical and pathological features and prognosis. Breast Cancer Res Treat 42: 23-30, 1997
18. 18. Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville AM: The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1-6, 1994
19. 19. Diel I, Kaufmann M, Krempien B, Kaul S, Corner R, Costa S, Bastert G: Immunocytochemical detection of tumor cells in bone marrow in patients with primary breast cancer. Br J Cancer 62(12): 3, 1990
20. 20. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9(10): 1749-1756, 1991
21. 21. Mansi JL, Berger U, Easton D, McDonnell T, Redding WH, Gazet JC, McKinne D, Powles TJ, Coombes RC: Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases. Br Med J 295: 1093-1096, 1987
22. 22. Osborne MP, Wong GY, Cote RJ, Liu J, Potter C, Killackey D, Old LJ, Rosen PP: Breast cancer micrometastases (BMM) in bone marrow: Detection by fluorescein-labeled monoclonal antibodies (MABS) predicts early relapse. Proc Am Soc Clin Oncol 10, 1991 (abstr)
23. 23. Vredenburgh JJ, Silva O, Broadwater G, Berry D, DeSombre K, Tyer C, Petros WP, Peters WP, Bast RC Jr: The significance of tumor contamination in the hone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hemalopoietic support. Biol Blood Marrow Transplant 3: 91-97, 1997
24. 24. U.I.C.C. International Union Against Cancer: TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. Berlin, Springer Verlag, Heidelberg, 1992
25. 25. Tagliabue E, Porro G, Barbanti P, Delia Torre G, Ménard S, Rilke F, Cerasoli S, Colnaghi MI: Improvement of tumor cell detection using a pool of monoclonal antibodies. Hybridoma 5: 107-115, 1986
26. 26. Molino A, Colombatti MI, Bonetti F, Zardini M, Pasini F, Perini A, Pelosi G, Tridente G, Veneri D, Cetto GL: A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer 67(4): 1033-1036, 1991
27. 27. Pelosi G, Bresaola E, Manfrin F, Rodella S, Schiavon I, lannucci A: Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human neoplasms using PC10, reactive with proliferating cell nuclear antigen (PCNA) and Ki67: a comparative study. Arch Pathol Lab Med 118: 510-516, 1994
28. 28. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
29. 29. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 50: 163-170, 1966
30. 30. Mantel N, Byar DP: Evaluation of response-time data involving transient states: An illustration using heart transplant data. J Am Stat Assoc 69: 81-86, 1974
31. 31. Menard S: Bone marrow micrometastases in breast cancer: Correlation with the tumor biology. Conference on cancer micrometastasis: biology, methodology, and clinical significance. Bethesda (USA), June 25, 1992 (abstr)
32. 32. Funke I, Schraut W: Meta-analyses of studies on hone marrow micrometastases: An independent prognostic impact remains to be substantiated. J Clin Oncol 16 (2): 557-566, 1998
33. 33. Cooper BW, Moss TJ, Ross AA, Ybanez. J, Lazarus HM: Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer. J Clin Oncol 16(11): 3509-3517, 1998
34. 34. Mansi JL, Berger T, McDonnell T, Rayter PZ, Gazet JC, Coombes RC: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7: 445-149, 1989